Ahmedabad (Gujarat) [India], August 10: Lincoln Pharmaceuticals Limited, one of India’s leading healthcare companies has continued to report excellent operational and financial performance for Q1 FY 2024-25 ended 30th June 2024. Company has reported a standalone net profit of Rs. 23.67 crore for the Q1 FY 2024-25 as compared to the net profit of Rs. […]
Continue Reading
Company has set a target of achieving Rs. 750 crore revenue by FY26 Business Highlights:- Among only 16 companies out of 4,200 plus listed companies in the Indian stock exchange to achieve the milestone of Profit Growth Every Single year from FY13 to FY23 as per the analysis of Morningstar. For FY23, company reported […]
Continue Reading
Total Income for Q1FY24 grew 10.27% Y-o-Y to Rs. 143.31 crore. Company has set a target of achieving Rs. 750 crore revenue by FY26 Financial Highlights (Standalone) Q1 FY24 Q1 FY23 Y-O-Y FY23 FY22 Y-O-Y Total Income 143.31 129.97 10.27% 532.79 482.08 10.52% EBITDA 28.41 23.41 21.36% 111.65 105.47 5.86% Profit before Tax 25.45 […]
Continue Reading